Pharmacy Website
    Clinic Website

    Intelligence » Eczema » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    Sanofi unveils eczema drug data, as regulators mull label expansion

    Monday, September 17, 2018 -- Sanofi has revealed details of research, which forms the basis of filings to extend the use of its eczema drug Dupixent (dupilumab) so it can be used to treat adolescents. Phase 3 trials of the targeted biologic medicine, which was tested on patie...

    Dupilumab Beneficial in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis

    Tuesday, September 18, 2018 -- The Phase 3 trial enrolled 251 patients aged 12-17 years old with moderate-to-severe atopic dermatitis, whose disease was not adequately controlled by prescription topical medications or for whom topical treatment was medically inadvisable.